It doesn't seem to matter what MSB does, good news or bad the share price generally only goes one way on any news.  I'll save you guessing, it's down.

MSB do have a lot going on, upcoming meetings are planned with FDA and an advisory board.  There was a paper published or going to be published in a prestigious, peer reviewed medical journal, the name escapes me, and MSB are intending to meet with the FDA after this. 

Their latest presentation can be found here https://investorsmedia.mesoblast.com/static-files/4e340912-0cd4-4ea5-b486-faa32fa44fad

Held ????